Fagan Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History

Fagan Associates’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,440	Closed	-$2.27M	–	121
2019 Q4	$2.27M	Buy	20,440 +165	+0.8%	+$17K	0.74%	41
2019 Q3	$2.01M	Buy	20,275 +550	+3%	+$54.6K	0.78%	40
2019 Q2	$1.96M	Buy	19,725 +355	+2%	+$33.9K	0.8%	35
2019 Q1	$2.14M	Buy	19,370 +1,245	+7%	+$130K	0.91%	33
2018 Q4	$1.67M	Buy	18,125 +515	+3%	+$52.1K	0.86%	38
2018 Q3	$1.94M	Buy	17,610 +1,370	+8%	+$143K	0.8%	40
2018 Q2	$1.52M	Buy	16,240 +195	+1%	+$16.8K	0.68%	47
2018 Q1	$1.33K	Buy	16,045 +1,995	+14%	+$177K	0.57%	52
2017 Q4	$1.28K	Buy	+14,050	New	+$1.17M	0.52%	55

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Fagan Associates's PRAH Position: Q1 2020 in Review

Fagan Associates sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 20,440 shares — an estimated $2.27M sold.

Fagan Associates first reported a position in PRAH in Q4 2017 and held it in 9 quarters. The position peaked at $2.27M in Q4 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

Fagan Associates reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
Fagan Associates sold 20,440 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $2.27M.
Fagan Associates first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 9 quarters.
Fagan Associates's PRA Health Sciences, Inc. position peaked at $2.27M in Q4 2019.
301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Fagan Associates's 13F filing for Q1 2020, filed 5 May 2020.